Exhibit 99.1

Keating Capital Reports Q1 2012 Results

Pre-IPO Investor Provides Financial Update

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--May 14, 2012--On May 10, 2012, Keating Capital, Inc. (“Keating” or the “Company”) reported financial results for the first quarter ended March 31, 2012.

Management Commentary

"Keating Capital operates a private-to-public valuation arbitrage strategy, seeking to profit from the potential value increase when a private company completes an IPO. Our goal is to make investments that create the potential for a 2x return on our investment once the company is publicly traded and assuming our typical investment horizon of 36 months,” stated Timothy J. Keating, CEO of Keating Capital, Inc. “To that end, we believe we have created a valuable portfolio that is performing well and which is in line with our overall expectations. During the first quarter, we added three new portfolio companies, sold stock in one portfolio company—which resulted in a realized capital gain of $132,930, which represents a return of 1.75x our investment cost,” added Mr. Keating.

Structural Protections

Of our investments in 15 private portfolio companies as of March 31, 2012, we have been provided some structural protection with respect to investments in eight of these portfolio companies. These structural protections typically include conversion rights upon an IPO which would result in our receiving shares of common stock at a discount to the IPO price upon conversion at the time of the IPO, or warrants that would result in our receiving additional shares for a nominal exercise price at the time of an IPO.

As of March 31, 2012, our structurally protected appreciation on these investments would, if each of these eight portfolio companies completed an IPO, result in an increase in our unrealized appreciation of $19.3 million at the time of the IPO.

• Four of these portfolio companies (with an aggregate cost and fair value of $15 million as of March 31, 2012) have structural protections that would, in the event of an IPO, entitle us to receive shares of common stock with a weighted-average aggregate value, at the time of issuance, of 1.52x our investment cost. We refer to this multiple as our structurally protected appreciation multiple.

• Four of these portfolio companies (with an aggregate cost of $13 million and an aggregate fair value of $14.6 million as of March 31, 2012) have a structurally protected appreciation multiple of 2.0x our investment cost upon an IPO.

Our ability to realize the structurally protected appreciation at the time of the IPO will depend on a number of factors including each portfolio company’s completion of an IPO, any adjustment to the special IPO conversion price that may be negotiated prior to or during the IPO process, the possible subsequent issuance of more senior securities that may impact the relative value of the structural protection, and fluctuations in the market price of each portfolio company’s common shares until such time as the common shares received upon conversion can be disposed of following the expiration of a customary 180-day post-IPO lockup period. Accordingly, the structurally protected appreciation would not be available unless each portfolio company completes an IPO. Further, even if an IPO is completed, the structurally protected appreciation would not be realized unless the market price of each portfolio company’s common shares equals or exceeds the IPO price at the time such shares are disposed of following the post-IPO lockup period.

Please refer to our quarterly report on Form 10-Q for the quarter ended March 31, 2012, for additional information on our structurally protected appreciation.

Q1 2012 Portfolio Investment Activity

Acquisitions

Keating Capital invested in the following new portfolio companies during the first quarter of 2012:

• Zoosk, Inc., $3.0 million in Series E Convertible Preferred Stock
• LifeLock, Inc., $5.0 million in Series E Convertible Preferred Stock and Convertible Preferred Stock Warrants
• SilkRoad Technology Holdings, Inc., $3.5 million in Series C Convertible Preferred Stock

All three of the new investments were direct investments in the most senior equity securities of the respective issuers and provide Keating Capital with full information rights until these companies complete an IPO.

Keating Capital also invested in the following existing portfolio companies during the first quarter of 2012:

• $527,500 in the common stock of Solazyme in open market transactions in January 2012
• $18,435 in the in the first tranche closing of the Series C-2 Convertible Preferred Stock round of Livescribe

Dispositions

During the first quarter of 2012, we sold 20,000 shares of our initial investment in Solazyme, resulting in net proceeds of $310,034 and a realized capital gain of $132,930. This was our first disposition of portfolio company securities and our first realized gain, which represented a 1.75x return on our investment cost in these shares over a holding period of 20 months. This compares to our targeted return of 2x our investment cost over our expected investment holding period of 36 months.

During the second quarter, we sold an additional 20,000 shares of Solazyme’s common stock, which resulted in net proceeds of $318,993 and a realized capital gain of $141,889 which was recorded in the second quarter. This realized gain represented a 1.8x return on our investment cost in these shares over a holding period of 21 months.

Recent Developments

On May 9, 2012, Keating Capital invested an additional $1.5 million in the Series C Convertible Preferred Stock of SilkRoad.

On May 10, 2012, Keating Capital invested $18,435 in the second tranche closing of the Series C-2 convertible preferred stock financing of Livescribe.

Stock Repurchase Program

On May 9, 2012, Keating Capital’s Board of Directors authorized a stock repurchase program of up to $5 million. The stock repurchase program will expire on November 8, 2012 unless extended by our Board.

Under the program, our management is authorized to repurchase shares in open market transactions, including through block purchases, depending on prevailing market conditions and other factors. We intend to fund the repurchases through our available liquidity, however, we are not obligated to repurchase any of our shares under this program.

Portfolio Investments

As of March 31, 2012, Keating Capital had a total of 17 portfolio company investments at an aggregate cost of $47.8 million. The fair value of the Company’s portfolio company investments was approximately $50.1 million, which includes approximately $2.3 million of net unrealized appreciation. We had approximately $26.9 million in cash and cash equivalents as of March 31, 2012, or approximately $2.89 per share.

Results of Operations

Change in Net Asset Value Per Share

In the first quarter, our net asset value per share decreased from $8.23 per share as of December 31, 2011, to $8.22 per share as of March 31, 2012, a decrease of $(0.01) per share, due primarily to:

• A decrease of $(0.13) per share attributable to our net investment loss of $1.2 million. Our net investment loss is the difference between our income from interest, dividends, fees and other investment income, and our operating expenses. Our net investment loss resulted from operating expenses of $1.2 million, offset by interest income of $1,742. Since we are focused on capital appreciation, we do not expected to generate current income (i.e., dividends or interest income), which makes us different from other business development companies that focus on making loans.
• An increase of $0.01 per share attributable to our net realized gain of $0.1 million on the sale of a portion of our Solazyme shares in the first quarter. Net realized gain (loss) on investments is the difference between the net proceeds of sales of portfolio company securities and their cost.
• An increase of $0.11 per share attributable to the net increase in unrealized appreciation on our investments of $1.0 million. The net change in unrealized appreciation (depreciation) is the change in the net unrealized appreciation (depreciation) of our portfolio company investments from the prior period, measured by the fair value of our portfolio company investments.

¹Per share data based on total common shares outstanding at the beginning and end of the corresponding period.

Capitalization

As of March 31, 2012, we had 9,283,781 shares of common stock issued and outstanding. There are no options, warrants, or other classes of securities issued or outstanding. Additionally, we had no debt. There were no capital stock transactions or distributions paid to stockholders in the first quarter.

Portfolio Analysis and Activity

For the quarter ended March 31, 2012, the net increase in our unrealized appreciation totaled $1.0 million. The primary components of this net increase were:

Other Information

Attached to this press release we have included the following:

• Our portfolio company investment summary as of March 31, 2012;
• Our statement of assets and liabilities as of March 31, 2012 (unaudited) and December 31, 2011; and
• Our statement of operations (unaudited) as of March 31, 2012 and 2011.

Stockholder Call

Keating Capital invites stockholders, analysts and interested parties to attend Keating Capital’s stockholder call on May 14, 2012, at 4:00 p.m. Eastern Time. You may pre-register at https://cc.readytalk.com/r/akg0qyazgt5e, and participate in the call by dialing (800) 754-1336.

A slide presentation will accompany the stockholder call and will be available at http://ir.keatingcapital.com/events.cfm in advance of the call. Select the Q1 2012 Earnings Call Slides link to download and print the presentation in advance of the stockholder call.

An archived audio replay of the stockholder call combined with the slide presentation will be available within approximately three hours of completion of the call at http://ir.keatingcapital.com/events.cfm. This archived recording will be available until the Company’s next quarterly earnings call which has been tentatively scheduled for August 15, 2012.

About Keating Capital, Inc.

Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, emerging growth companies that are committed to and capable of becoming public. We provide investors with the ability to participate in a unique fund that allows our stockholders to share in the potential value accretion that we believe typically occurs once a company transforms from private to public status. Keating Capital’s shares are listed on Nasdaq under the ticker symbol “KIPO.”

Forward-Looking Statements

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” set forth in Keating Capital’s Form 10-K and Form 10-Q filed with the Securities and Exchange Commission (“SEC”), and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s website has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.

CONTACT:
Keating Capital, Inc.
Investor Relations Contact:
Margie L. Blackwell, 720-889-0133
Investor Relations Director
mb@keatinginvestments.com
or
Public Relations Contact:
JCPR, Inc.
Chris Moon, 973-850-7304
chris@jcpr.com